⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
COCP News
Cocrystal Pharma, Inc. Common Stock
Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results
globenewswire.com
COCP
Form 8-K
sec.gov
COCP
Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection
globenewswire.com
COCP
Form 8-K
sec.gov
COCP
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
globenewswire.com
COCP
Form 8-K
sec.gov
COCP
Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
globenewswire.com
COCP
Form 8-K
sec.gov
COCP
Form 8-K
sec.gov
COCP
First Subjects Dosed in Cocrystal Pharma’s Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment
globenewswire.com
COCP